Ulrich S. Dischinger

Wuerzburg, BY 97078, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 61 publications

PYY3-36 potentiates semaglutide-mediated mitochondrial modulation in MASLD.

PYY3-36 potentiates semaglutide-mediated mitochondrial modulation in MASLD.

Journal: American journal of physiology. Endocrinology and metabolism

Published: July 29, 2026

PYY3-36 potentiates Semaglutide‑mediated mitochondrial modulation in MASLD.

PYY3-36 potentiates Semaglutide‑mediated mitochondrial modulation in MASLD.

Journal: American journal of physiology. Endocrinology and metabolism

Published: July 29, 2026

Does Automated Versus Manual Ki67 Labeling Index Assessment Influence Risk Stratification in Patients with Localized Adrenocortical Carcinoma? Lessons from the ADIUVO Trial.

Does Automated Versus Manual Ki67 Labeling Index Assessment Influence Risk Stratification in Patients with Localized Adrenocortical Carcinoma? Lessons from the ADIUVO Trial.

Journal: Cancers

Published: July 06, 2026

Impact of Neuroendocrine Neoplasm-Specific Systemic Treatments on Somatostatin Receptors Expression and Function in Neuroendocrine Tumor Cells.

Impact of Neuroendocrine Neoplasm-Specific Systemic Treatments on Somatostatin Receptors Expression and Function in Neuroendocrine Tumor Cells.

Journal: Cancers

Published: March 19, 2026

Reply to "Reporting inconsistencies in plasma AgRP for adrenocortical carcinoma".

Reply to "Reporting inconsistencies in plasma AgRP for adrenocortical carcinoma".

Journal: European journal of endocrinology

Published: February 01, 2026

Expert meeting report: epidemiology and management of acquired hypothalamic obesity.

Expert meeting report: epidemiology and management of acquired hypothalamic obesity.

Journal: Frontiers in endocrinology

Published: January 28, 2026

Sex-specific characterization of a novel metabolic osteoporosis phenotype induced by NOS-inhibition and Western diet in Wistar rats.

Sex-specific characterization of a novel metabolic osteoporosis phenotype induced by NOS-inhibition and Western diet in Wistar rats.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: November 10, 2025

Disruptive effects of phthalates and their substitutes on adrenal steroidogenesis.

Disruptive effects of phthalates and their substitutes on adrenal steroidogenesis.

Journal: Frontiers in endocrinology

Published: October 28, 2025

In-depth analysis of metabolic hormones and inflammatory markers following Roux-en-Y gastric bypass in humans and rodents: similarities and differences.

In-depth analysis of metabolic hormones and inflammatory markers following Roux-en-Y gastric bypass in humans and rodents: similarities and differences.

Journal: Diabetes research and clinical practice

Published: August 19, 2025

Reevaluating the use of metanephrine in adrenal vein sampling: a single centre retrospective study.

Reevaluating the use of metanephrine in adrenal vein sampling: a single centre retrospective study.

Journal: Endocrine connections

Published: July 01, 2025

Agouti-related peptide: a promising prognostic biomarker in adrenocortical carcinoma. Results from a large single-centre cross-sectional analysis.

Agouti-related peptide: a promising prognostic biomarker in adrenocortical carcinoma. Results from a large single-centre cross-sectional analysis.

Journal: European journal of endocrinology

Published: June 29, 2025

Efficacy and safety of relacorilant for the treatment of patients with Cushing's syndrome (GRACE): a multicentre, phase 3, double-blind, placebo-controlled, randomised-withdrawal study.

Efficacy and safety of relacorilant for the treatment of patients with Cushing's syndrome (GRACE): a multicentre, phase 3, double-blind, placebo-controlled, randomised-withdrawal study.

Journal: The lancet. Diabetes & endocrinology

Published: June 11, 2025

Showing 1-12 of 61

Last Updated: 09/26/2026